Our Life Sciences Group assists public and private companies and investors in the life sciences and pharmaceutical sectors. These include:

- Drug manufacturers

- Drug wholesalers and delivery companies

- Retail drug stores

- Biotechnology companies

- Medical device companies

- Pre-clinical and clinical research organizations

- Nutraceutical manufacturers

- Veterinary product manufacturers and distributors

- Cosmetics manufacturers and distributors

- Portfolio managers and venture capital investors.

Life science and pharmaceutical companies confidently rely on us to provide legal expertise on all aspects of their business affairs from pre-clinical trials to clinical testing of products, through to manufacturing, marketing and distribution. Our expertise is derived from a wealth of experience in research, protocol development, licensing, manufacturing, supply and commercialization agreements together with our commitment to deliver pragmatic solutions to our clients with speed and efficiency, backed by an effective use of technology.

Members of our Group also have extensive experience in all of the principal areas of equity investment including venture capital, IPOs, reverse take-over bids, mezzanine debt and equity capital. We advise on regulatory compliance, investments in funds and portfolio company acquisitions, including due diligence and acquisition, shareholder, financing and management agreements as well as the disposition, restructuring and reorganization of life science portfolio companies. We also provide specialized assistance dealing with competition and litigation issues such as assisting life sciences industry clients in their defense of product liability claims and class action litigation.

	Representative Transactions/Cases
			Advising drug manufacturers and wholesalers in connection with the distribution of pharmaceutical and over-the-counter (OTC) products, including negotiations with hospital buying groups and compliance with provincial marketing laws
			Advising the promoter of a retail pharmaceutical banner store system on all legal and regulatory issues relevant to its operations and the operation of its banner program
			Advising a global pharmaceutical company with respect to its clinical trial program

	Publications / Presentations
	November 2004 Legal Thoughts on Cross Border Deal Making Presented at the McMillan sponsored Toronto Biotechnology Initiative and Biotechnology Investments Today 'Alien' Partnering & Finance Conference
	October 2003 Private Equity in Canada Private Equity Bulletin Frank A. Archibald, Sean Farrell, Adam C. Maerov

Expand All Lists